Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.
Current Value
$4.371 Year Return
Current Value
$4.371 Year Return
Market Cap
$352.37M
P/E Ratio
-4.93
1Y Stock Return
120.92%
1Y Revenue Growth
-12.86%
Dividend Yield
0.00%
Price to Book
4.8
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Yahoo
REDWOOD CITY, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will attend the Piper Sandler 36th Annual Healthcare Conference, being held December 3-5, 2024, in New York, New York. Management will participate in a fireside chat on Tuesday, December 3, 2024, at 11:00 am ET. A live webcast of the event will be available in the Investor Relations secti
Finnhub
Corporate Presentation November 2024 We engineer enzymes Forward Looking Statements ...
Yahoo
—Becomes first company to showcase four routes of synthesis for approved siRNA therapeutic asset— —Joint poster with Bachem demonstrates superiority of Company’s double-stranded RNA ligases compared to wild-type enzymes— —Management to host conference call today at 4:30 pm EST to discuss data— REDWOOD CITY, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced data f
Yahoo
REDWOOD CITY, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Raymond De Vré, PhD, to the Company’s Board of Directors. “We are thrilled to have Raymond join the Codexis Board of Directors. He will be an invaluable resource to Codexis,” said Stephen Dilly, MBBS, PhD, Chairman and Chief Executive Officer at Codexis. “Raymond brings a deep unde
Yahoo
—Spotlight Presentation to showcase four routes of synthesis of an approved siRNA therapeutic asset— —Joint poster presentation with Bachem to compare Codexis double-stranded RNA ligase to wild-type enzymes— —Management to host conference call on Thursday, November 14 to discuss data— REDWOOD CITY, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company wil
Yahoo
REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the approval of an equity grant to one new employee as approved by the Compensation Committee of Codexis’ Board of Directors. The newly hired employee received an equity award consisting of (i) options to purchase 50,000 shares of Codexis common stock and (ii) 15,000 restricted stock units (RSUs) as
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AI | 52.41% | $4.44B | +21.49% | 0.00% |
DNLI | 48.75% | $3.49B | +33.81% | 0.00% |
PUBM | 48.02% | $773.82M | +0.25% | 0.00% |
DORM | 47.88% | $4.18B | +88.42% | 0.00% |
BEAM | 47.26% | $1.95B | -19.99% | 0.00% |
IPI | 46.04% | $352.77M | +39.08% | 0.00% |
TPIC | 45.55% | $92.75M | -14.66% | 0.00% |
KODK | 45.34% | $415.67M | +38.24% | 0.00% |
MGNI | 44.97% | $2.33B | +105.08% | 0.00% |
AA | 44.62% | $12.00B | +76.08% | 0.86% |
TILE | 44.40% | $1.47B | +152.35% | 0.16% |
MTUS | 44.21% | $639.54M | -26.12% | 0.00% |
ILPT | 44.21% | $242.09M | +22.61% | 1.08% |
RKT | 43.63% | $1.98B | +52.41% | 0.00% |
STHO | 43.60% | $149.31M | -8.49% | 0.00% |
RXRX | 43.59% | $1.65B | -15.19% | 0.00% |
CHPT | 43.51% | $487.69M | -42.64% | 0.00% |
ABCL | 43.40% | $803.40M | -38.60% | 0.00% |
RMBL | 43.39% | $219.65M | +2.99% | 0.00% |
DDD | 43.31% | $430.11M | -30.60% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VRSK | -0.01% | $40.61B | +19.80% | 0.52% |
AFL | -0.03% | $62.07B | +35.55% | 1.78% |
UNM | 0.03% | $13.77B | +76.53% | 2.07% |
LICY | 0.07% | $48.30M | -64.70% | 0.00% |
K | 0.07% | $27.93B | +52.93% | 2.77% |
REYN | 0.24% | $5.80B | +6.15% | 3.33% |
GD | 0.31% | $76.97B | +13.18% | 1.98% |
CASI | -0.32% | $70.36M | -6.25% | 0.00% |
AXS | -0.42% | $7.37B | +59.16% | 1.99% |
NXTC | 0.48% | $36.13M | +3.20% | 0.00% |
KNSL | 0.48% | $11.41B | +35.07% | 0.12% |
CCEC | 0.49% | $1.03B | +31.48% | 3.19% |
STVN | -0.52% | $5.35B | -29.32% | 0.29% |
KMB | 0.53% | $45.70B | +12.03% | 3.52% |
CPB | -0.61% | $13.23B | +8.54% | 3.29% |
GSK | 0.69% | $68.73B | -4.26% | 4.64% |
KO | 0.70% | $274.67B | +9.14% | 2.99% |
MDLZ | 0.80% | $86.64B | -9.37% | 2.70% |
CEPU | 0.81% | $2.10B | +88.69% | 0.00% |
NVS | 0.91% | $203.18B | +6.96% | 3.57% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PGR | -24.87% | $154.33B | +62.01% | 0.44% |
MCK | -21.21% | $79.75B | +37.34% | 0.41% |
AJG | -19.97% | $66.36B | +20.50% | 0.77% |
CAH | -15.63% | $29.87B | +16.57% | 1.63% |
MMC | -15.50% | $110.22B | +12.11% | 1.35% |
NERV | -15.07% | $15.46M | -55.98% | 0.00% |
LLY | -15.00% | $711.91B | +26.02% | 0.68% |
COR | -14.90% | $48.41B | +23.04% | 0.84% |
WRB | -14.37% | $23.68B | +34.33% | 0.68% |
ACGL | -14.14% | $37.09B | +20.63% | 0.00% |
CBOE | -13.79% | $22.09B | +17.17% | 1.08% |
ALL | -13.27% | $53.88B | +49.52% | 1.80% |
RSG | -12.91% | $67.03B | +33.78% | 1.01% |
RNR | -12.08% | $13.75B | +22.34% | 0.58% |
CL | -11.37% | $77.00B | +21.96% | 2.09% |
AON | -10.79% | $82.75B | +16.30% | 0.69% |
CME | -10.17% | $81.64B | +7.34% | 2.00% |
GIS | -9.74% | $35.60B | -1.16% | 3.70% |
EG | -9.31% | $16.55B | -5.60% | 1.93% |
CHD | -9.14% | $27.50B | +19.29% | 1.01% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
HDRO | 0.36% | $164.26M | 0.3% |
SOYB | -0.71% | $27.32M | 0.22% |
DBE | 0.89% | $50.92M | 0.77% |
IAK | 0.92% | $755.17M | 0.39% |
FLRN | 0.99% | $2.34B | 0.15% |
TAIL | -1.11% | $68.06M | 0.59% |
JBBB | -1.15% | $1.27B | 0.49% |
DBO | -1.21% | $218.38M | 0.77% |
CSHI | 1.45% | $486.73M | 0.38% |
CCOR | 1.51% | $108.59M | 1.18% |
CLOI | -1.75% | $720.91M | 0.4% |
GBIL | 2.03% | $5.64B | 0.12% |
AGZD | -2.05% | $142.85M | 0.23% |
DBA | -2.39% | $768.98M | 0.93% |
CANE | 2.47% | $17.43M | 0.29% |
JUCY | -2.70% | $325.31M | 0.6% |
HIGH | -3.05% | $301.36M | 0.51% |
COMT | 3.30% | $842.63M | 0.48% |
MINT | -3.43% | $11.62B | 0.35% |
DBMF | -3.75% | $1.02B | 0.85% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -49.83% | $379.51M | 1.43% |
USDU | -29.87% | $201.83M | 0.5% |
UUP | -25.54% | $359.07M | 0.77% |
EQLS | -20.69% | $8.88M | 1% |
VIXY | -16.98% | $195.31M | 0.85% |
CTA | -7.38% | $359.48M | 0.78% |
CORN | -6.62% | $61.32M | 0.2% |
KRBN | -6.51% | $243.28M | 0.85% |
FLTR | -5.64% | $1.79B | 0.14% |
BSCO | -5.30% | $2.31B | 0.1% |
WEAT | -5.20% | $123.26M | 0.28% |
KCCA | -4.84% | $219.64M | 0.87% |
VRIG | -4.53% | $1.09B | 0.3% |
KMLM | -4.04% | $348.59M | 0.9% |
DBMF | -3.75% | $1.02B | 0.85% |
MINT | -3.43% | $11.62B | 0.35% |
HIGH | -3.05% | $301.36M | 0.51% |
JUCY | -2.70% | $325.31M | 0.6% |
DBA | -2.39% | $768.98M | 0.93% |
AGZD | -2.05% | $142.85M | 0.23% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ARKG | 55.13% | $1.14B | 0.75% |
SDVY | 53.19% | $7.28B | 0.6% |
IWC | 52.95% | $943.89M | 0.6% |
PBD | 52.94% | $86.94M | 0.75% |
DFAT | 52.90% | $11.29B | 0.28% |
IJJ | 52.89% | $8.05B | 0.18% |
DFSV | 52.87% | $4.18B | 0.31% |
AVUV | 52.55% | $15.38B | 0.25% |
GNOM | 52.53% | $71.22M | 0.5% |
RZV | 52.21% | $255.81M | 0.35% |
IWM | 51.80% | $75.93B | 0.19% |
ACES | 51.65% | $120.86M | 0.55% |
PRFZ | 51.30% | $2.64B | 0.39% |
PBW | 51.23% | $297.98M | 0.65% |
IJS | 51.20% | $7.36B | 0.18% |
VTWO | 51.15% | $12.48B | 0.1% |
FYX | 51.07% | $972.31M | 0.6% |
ESML | 50.98% | $1.91B | 0.17% |
MDYV | 50.97% | $3.65B | 0.15% |
SLYV | 50.94% | $4.12B | 0.15% |